CD44 and neoplasm: While tumor-rechallenge experiments are needed to fully confirm long-term immunity, the observed expansion of memory T-cell subsets (CD44+ CD62L−TEM) and sustained tumor-free survival strongly suggest that VVL-GL7 induces durable immune memory.